Cargando…

Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets

Mostrar otras versiones (1)

Research focusing on type 1 diabetes (T1D) autoantigens aims to explore our understanding of these beta cell proteins in order to design assays for monitoring the pathogenic autoimmune response, as well as safe and efficient therapies preventing or stopping it. In this review, we will discuss progre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mauvais, François-Xavier, Diana, Julien, van Endert, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847563/ https://www.ncbi.nlm.nih.gov/pubmed/27158463 http://dx.doi.org/10.12688/f1000research.7411.1

Ejemplares similares

Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets
por: Moser, Anna, et al.
Publicado: (2010)

No Major Role for Insulin-Degrading Enzyme in Antigen Presentation by MHC Molecules
por: Culina, Slobodan, et al.
Publicado: (2014)

IRAP Endosomes Control Phagosomal Maturation in Dendritic Cells
por: Weimershaus, Mirjana, et al.
Publicado: (2020)

Kinesin-1 regulates antigen cross-presentation through the scission of tubulations from early endosomes in dendritic cells
por: Belabed, Meriem, et al.
Publicado: (2020)

Editorial: Insights in antigen presenting cell biology: 2021
por: van Endert, Peter
Publicado: (2022)

Editorial: Insights in antigen presenting cell biology: 2022
por: van Endert, Peter
Publicado: (2023)

Compromised mitochondrial quality control triggers lipin1-related rhabdomyolysis
por: Hamel, Yamina, et al.
Publicado: (2021)

Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model
por: Martin, Sarah B, et al.
Publicado: (2011)

The Role of Insulin-Regulated Aminopeptidase in MHC Class I Antigen Presentation
por: Saveanu, Loredana, et al.
Publicado: (2012)

The Impact of Pancreatic Beta Cell Heterogeneity on Type 1 Diabetes Pathogenesis
por: Benninger, Richard K. P., et al.
Publicado: (2018)

Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells
por: Montealegre, Sebastian, et al.
Publicado: (2019)

Confirmation and Identification of Biomarkers Implicating Environmental Triggers in the Pathogenesis of Type 1 Diabetes
por: Harms, Robert Z., et al.
Publicado: (2020)

Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma
por: Medhat, Arvin, et al.
Publicado: (2021)

Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
por: Mauvais-Jarvis, Franck
Publicado: (2017)

Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis
por: Toren, Eliana, et al.
Publicado: (2021)

Pneumolysin: Pathogenesis and Therapeutic Target
por: Nishimoto, Andrew T., et al.
Publicado: (2020)

The miRNA Profile of Human Pancreatic Islets and Beta-Cells and Relationship to Type 2 Diabetes Pathogenesis
por: van de Bunt, Martijn, et al.
Publicado: (2013)

New Insights into Diabetic Kidney Disease: The Potential Pathogenesis and Therapeutic Targets
por: Liu, Wei Jing, et al.
Publicado: (2017)

Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies
por: Sucher, Elisabeth, et al.
Publicado: (2019)

The Pathogenesis of Sepsis and Potential Therapeutic Targets
por: Huang, Min, et al.
Publicado: (2019)

Mycobacterium tuberculosis: Pathogenesis and therapeutic targets
por: Yang, Jiaxing, et al.
Publicado: (2023)

The pathogenesis and potential therapeutic targets in sepsis
por: Zhang, Wendan, et al.
Publicado: (2023)

Arginase 2 and Polyamines in Human Pancreatic Beta Cells: Possible Role in the Pathogenesis of Type 2 Diabetes
por: Marselli, Lorella, et al.
Publicado: (2021)

Editorial: Organ Fibrosis: Pathogenesis, Biomarkers and Therapeutic Targets
por: Mutsaers, Henricus A. M., et al.
Publicado: (2021)

Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets
por: Sabol, Maja, et al.
Publicado: (2018)

Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention
por: Richardson, Sarah J, et al.
Publicado: (2018)

Do Anti-androgens Have Potential as Therapeutics for COVID-19?
por: Mauvais-Jarvis, Franck
Publicado: (2021)

Tough antigens trigger immunity
por: Van Epps, Heather L.
Publicado: (2006)

The Pathogenesis and Therapeutic Approaches of Diabetic Neuropathy in the Retina
por: Oshitari, Toshiyuki
Publicado: (2021)

Gut microbiota in the pathogenesis and therapeutic approaches of diabetes
por: Crudele, Lucilla, et al.
Publicado: (2023)

Pathogenesis and New Therapeutic Targets of Ovarian Cancer
por: Shih, Ie-Ming, et al.
Publicado: (2012)

Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta
por: Jena, Manoj Kumar, et al.
Publicado: (2020)

Neutrophils in liver diseases: pathogenesis and therapeutic targets
por: Liu, Kai, et al.
Publicado: (2020)

Exosomes in brain diseases: Pathogenesis and therapeutic targets
por: Si, Qingying, et al.
Publicado: (2023)

Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options
por: Artasensi, Angelica, et al.
Publicado: (2023)

Novel Antigenic Targets of HPV Therapeutic Vaccines
por: Boilesen, Ditte Rahbæk, et al.
Publicado: (2021)

Beware the algorithm
por: van Endert, Peter
Publicado: (2021)

Targeting pancreatic beta cell death in type 2 diabetes by polyphenols
por: García-Aguilar, Ana, et al.
Publicado: (2022)

Oxidative stress in genetically triggered thoracic aortic aneurysm: role in pathogenesis and therapeutic opportunities
por: Portelli, Stefanie S., et al.
Publicado: (2021)

Self-Antigens Targeted by Regulatory T Cells in Type 1 Diabetes
por: Mitchell, Angela M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m39jj5ugq1lmmuam431bj1rcn6